These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 24925370)

  • 1. The role of the SHH gene in prostate cancer cell resistance to paclitaxel.
    Statkiewicz M; Maryan N; Lipiec A; Grecka E; Grygorowicz MA; Omiotek M; Gorska A; Mikula M; Malecki M
    Prostate; 2014 Aug; 74(11):1142-52. PubMed ID: 24925370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carnosol inhibits Hedgehog signaling pathway in both LNCaP and DU145 prostate cancer cell lines.
    Gao H; Song Q; Yang J; Yu S; Zhao J; Yu G
    Cell Mol Biol (Noisy-le-grand); 2017 Aug; 63(8):104-108. PubMed ID: 28886322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of ceritinib (LDK378) on enhancement of chemotherapeutic agents in ABCB1 and ABCG2 overexpressing cells in vitro and in vivo.
    Hu J; Zhang X; Wang F; Wang X; Yang K; Xu M; To KK; Li Q; Fu L
    Oncotarget; 2015 Dec; 6(42):44643-59. PubMed ID: 26556876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SET protein overexpression contributes to paclitaxel resistance in MCF-7/S cells through PI3K/Akt pathway.
    Zhang W; Zheng X; Meng T; You H; Dong Y; Xing J; Chen S
    J Drug Target; 2017 Mar; 25(3):255-263. PubMed ID: 27718638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hedgehog signaling promotes multidrug resistance by regulation of ABC transporters in oral squamous cell carcinoma.
    Lu X; Wang Z; Huang H; Wang H
    J Oral Pathol Med; 2020 Oct; 49(9):897-906. PubMed ID: 32512620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of PER3 reverses paclitaxel resistance of prostate cancer cells by inhibiting the Notch pathway.
    Cai DW; Chen D; Sun SP; Liu ZJ; Liu F; Xian SZ; Wu PS; Kong GQ
    Eur Rev Med Pharmacol Sci; 2018 May; 22(9):2572-2579. PubMed ID: 29771413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcriptional targeting of human liver carboxylesterase (hCE1m6) and simultaneous expression of anti-BCRP shRNA enhances sensitivity of breast cancer cells to CPT-11.
    Mishra MN; Vangara KK; Palakurthi S
    Anticancer Res; 2014 Nov; 34(11):6345-51. PubMed ID: 25368234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The establishment of two paclitaxel-resistant prostate cancer cell lines and the mechanisms of paclitaxel resistance with two cell lines.
    Takeda M; Mizokami A; Mamiya K; Li YQ; Zhang J; Keller ET; Namiki M
    Prostate; 2007 Jun; 67(9):955-67. PubMed ID: 17440963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gambogic acid increases the sensitivity to paclitaxel in drug‑resistant triple‑negative breast cancer via the SHH signaling pathway.
    Wang Y; Sui Y; Tao Y
    Mol Med Rep; 2019 Nov; 20(5):4515-4522. PubMed ID: 31545492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sonic hedgehog and androgen signaling in tumor and stromal compartments drives epithelial-mesenchymal transition in prostate cancer.
    Yamamichi F; Shigemura K; Behnsawy HM; Meligy FY; Huang WC; Li X; Yamanaka K; Hanioka K; Miyake H; Tanaka K; Kawabata M; Shirakawa T; Fujisawa M
    Scand J Urol; 2014 Dec; 48(6):523-32. PubMed ID: 25356787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulation of cytokeratin 18 is associated with paclitaxel‑resistance and tumor aggressiveness in prostate cancer.
    Yin B; Zhang M; Zeng Y; Li Y; Zhang C; Getzenberg RH; Song Y
    Int J Oncol; 2016 Apr; 48(4):1730-6. PubMed ID: 26892177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene expression profiling of adenosine triphosphate-binding cassette transporters in response to K-ras activation and hypoxia in human pancreatic cancer cell cultures.
    Lo M; Tsao MS; Hedley D; Ling V
    Pancreas; 2009 Jan; 38(1):85-93. PubMed ID: 19117087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of acquired paclitaxel resistance of breast cancer cells and involvement of ABC transporters.
    Němcová-Fürstová V; Kopperová D; Balušíková K; Ehrlichová M; Brynychová V; Václavíková R; Daniel P; Souček P; Kovář J
    Toxicol Appl Pharmacol; 2016 Nov; 310():215-228. PubMed ID: 27664577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sonic hedgehog signaling is associated with resistance to zoledronic acid in CD133high/CD44high prostate cancer stem cells.
    Acikgoz E; Mukhtarova G; Alpay A; Avci CB; Bagca BG; Oktem G
    Mol Biol Rep; 2021 Apr; 48(4):3567-3578. PubMed ID: 33948856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytotoxicity of herbal extracts used for treatment of prostatic disease on head and neck carcinoma cell lines and non-malignant primary mucosal cells.
    Schmidt M; Polednik C; Roller J; Hagen R
    Oncol Rep; 2013 Feb; 29(2):628-36. PubMed ID: 23165347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenovirus-mediated inhibition of survivin expression sensitizes human prostate cancer cells to paclitaxel in vitro and in vivo.
    Zhang M; Mukherjee N; Bermudez RS; Latham DE; Delaney MA; Zietman AL; Shipley WU; Chakravarti A
    Prostate; 2005 Aug; 64(3):293-302. PubMed ID: 15754318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Preliminary study of the prohibitin protein and paclitaxel resistance in ovarian cancer].
    Tang J; Cao L; Yi H; Tang C
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2012 Dec; 37(12):1221-7. PubMed ID: 23281375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sonic Hedgehog promotes multiple drug resistance by regulation of drug transport.
    Sims-Mourtada J; Izzo JG; Ajani J; Chao KS
    Oncogene; 2007 Aug; 26(38):5674-9. PubMed ID: 17353904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inactivation of Id-1 in prostate cancer cells: A potential therapeutic target in inducing chemosensitization to taxol through activation of JNK pathway.
    Zhang X; Ling MT; Wang X; Wong YC
    Int J Cancer; 2006 Apr; 118(8):2072-81. PubMed ID: 16287090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microvesicle- and exosome-mediated drug delivery enhances the cytotoxicity of Paclitaxel in autologous prostate cancer cells.
    Saari H; Lázaro-Ibáñez E; Viitala T; Vuorimaa-Laukkanen E; Siljander P; Yliperttula M
    J Control Release; 2015 Dec; 220(Pt B):727-37. PubMed ID: 26390807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.